Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effect of Dexmedetomidine on the Inflammatory Response in Children Under Congenital Heart Disease Repair With Cardiopulmonary Bypass: A Randomized Controlled Clinical Trial

Trial Profile

The Effect of Dexmedetomidine on the Inflammatory Response in Children Under Congenital Heart Disease Repair With Cardiopulmonary Bypass: A Randomized Controlled Clinical Trial

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Jul 2018

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Postoperative inflammation; Sedation
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Jul 2018 Planned End Date changed from 1 May 2018 to 1 Dec 2018.
    • 06 Jul 2018 Planned primary completion date changed from 1 May 2018 to 1 Oct 2018.
    • 06 Jun 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top